Bluejay Diagnostics Inc.

NASDAQ: BJDX · Real-Time Price · USD
1.38
0.07 (5.34%)
At close: Aug 15, 2025, 12:40 PM

Bluejay Diagnostics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a 249.04K n/a
Cost of Revenue
199.1K 780.96K 200.13K 145.72K
Gross Profit
-199.1K -780.96K 48.91K -145.72K
Operating Income
-7.17M -10.31M -9.32M -3.23M
Interest Income
145.82K 164.9K 89.67K 513.3K
Pretax Income
-7.72M -9.95M -9.3M -3.49M
Net Income
-7.72M -9.95M -9.3M -3.73M
Selling & General & Admin
3.7M 4.6M 5.21M 2.08M
Research & Development
3.47M 5.71M 4.15M 1.15M
Other Expenses
n/a n/a n/a -145.72K
Operating Expenses
7.17M 10.31M 9.37M 3.08M
Interest Expense
823.03K n/a n/a 367.46K
Selling & Marketing Expenses
8.3K 283.44K 451.42K 289.73K
Cost & Expenses
-7.17M 10.31M 9.57M 3.23M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
183.39K 137.06K 126.02K 125.7K
Shares Outstanding (Diluted)
183.39K 137.06K 126.02K 125.7K
EPS (Basic)
-42.08 -72.62 -73.22 -29.67
EPS (Diluted)
-42.08 -72.62 -73.22 -29.67
EBITDA
-6.7M -9.17M -8.99M -3.08M
EBIT
-6.89M -9.95M -9.32M -3.23M
Depreciation & Amortization
199.1K 780.96K 306.37K 145.72K